In-vitro production method of high-quality mitochondria and application of high-quality mitochondria in transplantation therapy
Through customized serum-free medium optimization system, the problem of high-quality mitochondrial production in mitochondrial transplantation treatment is solved, the sustainable production of highly active mitochondria and the treatment effect of various diseases is achieved, and the limitations of traditional serum culture media are broken.
Patent Information
- Application Number
- CN202410935349.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-12
- Publication Date
- 2024-11-26
AI Technical Summary
In the prior art, mitochondrial transplantation treatment faces the problems of sustainable and controllable production of high-quality mitochondria. Traditional serum culture media has problems such as quality instability, ethical problems and immune rejection, which is difficult to meet clinical needs.
Using customized serum-free culture medium, including basic fibroblast growth factor, insulin-transferrin-selenium, human platelet lysate and other components, the ability of cell proliferation and mitochondrial biosynthesis is significantly improved through the optimization of the culture system, and high activity is obtained. , high-quality mitochondria.
It has achieved sustainable and controllable production of high-quality mitochondria, significantly improved the activity and function of mitochondria, and used for the treatment of tissue regeneration, aging and a variety of diseases, breaking through the limitations of traditional serum culture media, and reducing costs.
Smart Images

Figure CN119020276A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the field of biomedicine technology, and in particular, relates to a method for producing high-quality mitochondria in vitro and an application thereof in transplantation therapy. Background Art
[0002] The description of the background technology is merely a general description for facilitating understanding of the present invention and does not constitute any limitation to the present invention.
[0003] Clinically, mitochondrial transplantation is considered a promising strategy for the treatment of metabolic-related diseases, including ischemia-reperfusion injury, mitochondrial DNA (mtDNA) diseases, and infertility. In these clinical scenarios, healthy mitochondria need to be collected in vitro and implanted into recipients to correct metabolic abnormalities. However, there is still a long-standing problem in obtaining safe and functional mitochondria. As mentioned above, mitochondria contain well-organized double membrane structures and complex chemical mechanisms, making them a real challenge for de novo artificial synthesis. Therefore, mitochondria-rich tissues, such as liver or muscle, remain the main mitochondrial resources for clinical use. However, these mitochondria are isolated from non-expandable tissues by invasive procedures and cannot continuously meet the new needs of mitochondrial therapy. In addition, the quality of mitochondria cannot be well controlled, which varies depending on the age and health status of the donor. Therefore, there is still a huge gap between current mitochondrial harvesting and efficient mitochondrial manufacturing. It is imperative to develop new strategies to ensure the sustainable and controllable production of high-quality human mitochondria.
[0004] Cell engineering technology can manipulate the cell fate and function of various cell types. In this regard, since stem cells have the ability to self-renew in long-term culture, they can provide a good platform for the manufacture of cell derivatives. However, there is still a lack of engineering research on the production of organelles (mitochondria), which may require more complex regulation. Therefore, in order to meet the production and sustainable mitochondrial manufacturing of the present invention, it is necessary to customize the culture conditions of stem cells, thereby providing conditions that promote cell proliferation and mitochondrial biogenesis at the same time.
[0005] Adipose-derived mesenchymal stem cells are adult stem cells isolated from adipose tissue, which have strong self-renewal ability and multidirectional differentiation potential. Human adipose-derived mesenchymal stem cells can be induced to differentiate into mesodermal cells such as osteoblasts, chondrocytes, skeletal muscle cells, and liver cells under specific conditions, and can also differentiate into other germ layers, with the function of repairing tissue and organ damage. Adipose-derived mesenchymal stem cells are abundant in source, easy to collect, easy to separate and culture, not subject to ethical controversy, have low immunogenicity and have immunosuppressive properties, so they have great application prospects in the field of regenerative medicine. Clinical research has a great demand for adipose-derived mesenchymal stem cells, but it is currently difficult to obtain enough adipose-derived mesenchymal stem cells from patients and donors, which has become a limitation to their clinical application, so it is necessary to establish appropriate conditions for in vitro expansion.
[0006] In the traditional scheme, a culture medium containing a certain proportion of fetal bovine serum (FBS) is mainly used to expand mesenchymal stem cells. Although fetal bovine serum contains nutrients required for cell proliferation, such as proteins, hormones, growth factors and adhesion promoting factors, it also has some problems: it may contain unknown animal-derived proteins, bacteria, viruses, etc., which will bring potential risks to clinical research; the quality of serum is closely related to the age, gender, and health of the donor, and there are large differences between different batches, which can easily lead to unstable cell quality; in addition, there are ethical issues in serum collection; and there are problems with residual foreign proteins, which may lead to immune rejection reactions in the body and interfere with the treatment effect. Currently, commercial serum-free culture media mainly include StemPro MSC SFM XenoFree (Gibco), Mesenchymal Stem Cell Growth Medium XF (PromoCell), etc. Serum-free culture media can ensure cell growth and proliferation, maintain the phenotype and tri-lineage differentiation of mesenchymal stem cells, but there are problems such as poor cell proliferation after several generations of culture, complex ingredients, and high prices.
[0007] In the Chinese invention patent "Application of iMSCs mitochondria in the preparation of drugs for the treatment of bone defects" with application publication number CN117180312A, mitochondria are also isolated by in vitro culture of iMSCs to treat bone defects. However, on the one hand, the in vitro production method of mitochondria in this application is completely different from that of the present invention, which uses complete culture medium for culture. At the same time, in some embodiments of the present invention, it is further verified that compared with mitochondria obtained by culture using complete culture medium in the comparative document, mitochondria obtained by culture and isolation using the customized serum-free culture system of the present invention have more significant cartilage damage repair effects.
[0008] Therefore, it is urgent to develop an adipose-derived mesenchymal stem cell culture medium that can effectively enhance cell proliferation and mitochondrial biosynthesis without the addition of serum, and then successfully construct mitochondria-rich stem cells for mitochondrial production and mitochondrial transplantation therapy. The mitochondria finally cultured and isolated by the culture medium show extremely significant effects in anti-aging and the treatment of many diseases, and are expected to provide a practical solution to the many problems currently faced by mitochondrial transplantation therapy. At the same time, it is expected to provide a new treatment strategy and preparation based on mitochondrial transplantation for the treatment of some intractable diseases in the clinic, which has very important scientific research value and clinical treatment significance. Summary of the invention
[0009] In order to solve the problems existing in the prior art, the present invention provides a method for producing high-quality mitochondria in vitro and its application in transplantation therapy. In view of the large demand for high-quality mitochondria in clinical practice, a customized mesenchymal stem cell (MSCs) culture system is successfully established by optimizing the culture system on a large scale. Under this system, the culture medium can significantly improve the cell proliferation ability and mitochondrial biosynthesis ability of MSCs without adding serum, thereby obtaining a large number of high-quality mitochondria; the separated mitochondria can not only be used for the treatment of tissue regeneration, aging and aging degenerative diseases, but also in the treatment of other diseases such as cardiovascular diseases and immune diseases, the effect is also very significant. The present invention breaks through the limitations of traditional serum culture medium, customizes the culture medium without animal-derived components, has lower cost, can obtain stem cells rich in mitochondria, and the extracted mitochondria are stable in source and highly active, which can meet the needs of mitochondrial transplantation therapy, and provides strong technical support and new ideas for the sustainable and controllable production of high-quality mitochondria, and has good application prospects.
[0010] In order to achieve the above object, the present invention adopts the following scheme:
[0011] In one aspect, the present invention provides a method for producing highly active mitochondria in vitro, comprising the following steps:
[0012] (1) Preparing a customized serum-free culture medium;
[0013] (2) inoculating cells and culturing them using the serum-free medium in step (1);
[0014] (3) Isolation of mitochondria;
[0015] The serum-free culture medium in step (1) comprises basic fibroblast growth factor, insulin-transferrin-selenium, and human platelet lysate, and the three components synergistically enhance the mitochondrial activity; in the serum-free culture medium, the basal culture medium is DMEM / F12 culture medium and 1% penicillin / streptomycin.
[0016] In some embodiments, a customized culture system is preferably used to have the best synergistic culture system, thereby significantly improving the cell proliferation ability and mitochondrial biosynthesis ability. The mesenchymal stem cells obtained by the culture have a stronger proliferation ability and meet the standards for mesenchymal stromal cells established by the International Society for Cell Therapy, as well as better adipogenic, chondrogenic, and osteogenic differentiation abilities and stronger cloning ability. At the same time, the mitochondria isolated from human adipose stem cells have more mitochondria, a significantly increased protein content, and significantly more ATP is produced, while the reactive oxygen content is significantly reduced, and the cells have stronger activity and function.
[0017] In order to further improve the culture effect of serum-free culture medium, the optimal components in serum-free culture medium were further screened. The results showed that basic fibroblast growth factor promotes cell proliferation and differentiation and stimulates cell growth, while insulin-transferrin-selenium provides necessary nutrition and metabolic support for cells and ensures normal cell metabolism. When basic fibroblast growth factor, insulin-transferrin-selenium and human platelet lysate are used synergistically, they work synergistically by jointly regulating intracellular signal pathways and affecting gene expression, further stimulating cell growth and ensuring normal cell metabolism, thereby significantly improving mitochondrial function and ultimately significantly promoting the enhancement of mitochondrial activity.
[0018] Moreover, when any one component in the optimal culture medium of the present invention is deleted arbitrarily, the relative mitochondrial activity obtained by culture decreases, which indicates that each component in the customized culture system of the present invention can promote mitochondrial activity and is an indispensable component. Moreover, under the synergistic effect of different components, the mitochondrial activity obtained by culture can be significantly enhanced.
[0019] Furthermore, the serum-free culture medium also includes sodium bicarbonate, lipid concentrate, progesterone, hydrocortisone, L-ascorbic acid, and heparin sodium.
[0020] Furthermore, the serum-free culture medium includes 1-5 g / L sodium bicarbonate, 1X insulin-transferrin-selenium, 5-10 ng / ml basic fibroblast growth factor, 0.1%-1% lipid concentrate, 10-50 nM progesterone, 10-100 nM hydrocortisone, 10-200 μM L-ascorbic acid, 1-100 μg / ml heparin sodium, and 1%-5% human platelet lysate.
[0021] In some embodiments, the insulin-transferrin-selenium 1X means that it contains 5-20 μg / ml insulin, 2-10 μg / ml transferrin, and 20-100 ng / ml selenium.
[0022] On the other hand, the present invention provides a high-activity mitochondrial preparation, wherein the mitochondria in the preparation are cultured and isolated using the in vitro production method described in any one of the above technical solutions.
[0023] On the other hand, the present invention provides a use of a serum-free culture medium for preparing a preparation for promoting cartilage repair, wherein the serum-free culture medium is used to culture and isolate highly active mitochondria in vitro, and a highly active mitochondrial preparation is prepared, and the highly active mitochondrial preparation is transplanted to promote the repair of cartilage damage.
[0024] In some embodiments, in order to verify the repair effect of high-quality mitochondria cultured and isolated by the customized culture system of the present invention on cartilage damage after transplantation, a mouse OA model was constructed, and the results showed that compared with the sterile PBS group and the ordinary mitochondria group, the cartilage surface of the mice injected with high-energy mitochondria group was smoother and flatter, reducing the loss of cartilage matrix components caused by osteoarthritis cartilage destruction; and in the sterile PBS group and the ordinary mitochondria group, the damage to the knee cartilage of the mice was significantly aggravated over time; while in the mice injected with high-energy mitochondria group, the cartilage was significantly repaired. This shows that the high-energy mitochondria cultured by the present invention can significantly promote the repair of OA cartilage in mice after transplantation.
[0025] Furthermore, the serum-free culture medium includes a basic culture medium of DMEM / F12 culture medium and 1% penicillin / streptomycin; and also includes basic fibroblast growth factor, insulin-transferrin-selenium, human platelet lysate, sodium bicarbonate, lipid concentrate, progesterone, hydrocortisone, L-ascorbic acid, heparin sodium, and penicillin / streptomycin. The ten components synergistically enhance the activity of mitochondria to prepare a highly active mitochondrial preparation.
[0026] Furthermore, the serum-free culture medium includes 1-5 g / L sodium bicarbonate, 1X insulin-transferrin-selenium, 5-10 ng / ml basic fibroblast growth factor, 0.1%-1% lipid concentrate, 10-50 nM progesterone, 10-100 nM hydrocortisone, 10-200 μM L-ascorbic acid, 1-100 μg / ml heparin sodium, and 1%-5% human platelet lysate.
[0027] On the other hand, the present invention provides a use of a serum-free culture medium for preparing a preparation for reducing the fat content, increasing the muscle content, reducing the abdominal fat content, or increasing the movement distance and movement speed of aged mice, characterized in that the serum-free culture medium is used to culture and isolate highly active mitochondria in vitro, and a highly active mitochondrial preparation is prepared. After the highly active mitochondrial preparation is transplanted, the aging indicators of aged mice are improved, the fat content is reduced, and the muscle content is increased.
[0028] In some embodiments, in order to study the anti-aging effect of high-quality mitochondria produced and separated by the customized culture system of the present invention after transplantation, a verification experiment was carried out, and the results showed that: compared with the sterile PBS group, the aging indicators of mitochondrial transplanted mice were significantly improved: after the experimental group transplanted mitochondria obtained by the culture of the present invention, the body fat content of the aged mice was significantly reduced, and the muscle content was significantly increased; at the same time, the abdominal fat content of the mice in the mitochondrial transplantation group was also significantly reduced; in addition, the open field experiment showed that the exercise ability of the mice in the mitochondrial transplantation group was significantly stronger than that of the control group, which was manifested as an increase in exercise distance and exercise speed; the improvement of the above indicators all indicate that the high-quality mitochondria produced and separated by the customized culture system of the present invention have potential application value in the treatment of aging and aging degenerative diseases after transplantation.
[0029] Furthermore, the serum-free culture medium includes a basic culture medium of DMEM / F12 culture medium and 1% penicillin / streptomycin; and also includes basic fibroblast growth factor, insulin-transferrin-selenium, human platelet lysate, sodium bicarbonate, lipid concentrate, progesterone, hydrocortisone, L-ascorbic acid, and heparin sodium. The nine components synergistically enhance the activity of mitochondria to prepare a highly active mitochondrial preparation.
[0030] On the other hand, the present invention provides a serum-free culture medium for preparing a preparation for improving the energy metabolism of cardiomyocytes, enhancing myocardial contractility or regulating the redox balance in cells, reducing oxidative stress damage of neurons or restoring the activity of liver cells, characterized in that the serum-free culture medium includes a basic culture medium of DMEM / F12 culture medium and 1% penicillin / streptomycin; and also includes basic fibroblast growth factor, insulin-transferrin-selenium, human platelet lysate, sodium bicarbonate, lipid concentrate, progesterone, hydrocortisone, L-ascorbic acid, and heparin sodium. The nine components synergistically enhance mitochondrial activity to prepare a high-activity mitochondrial preparation.
[0031] In some embodiments, further research has been conducted on the application of mitochondria obtained by culture and separation of the present invention in various other diseases. The experimental results of the preliminary study show that: in the treatment of cardiovascular diseases, after the mitochondria are transplanted, they can effectively improve the energy metabolism of myocardial cells, enhance myocardial contractility, and provide the energy required for the normal functioning of the heart; in nervous system diseases, such as Parkinson's disease, after the mitochondria are transplanted, the redox balance in the cells can be successfully regulated, the oxidative stress damage of neurons can be reduced, and the normal function of neurons can be maintained; in the treatment of fatty liver, after the mitochondria are transplanted, the energy production of the liver can be effectively improved, the lipid accumulation and oxidative damage in the liver can be reduced, and the activity of liver cells can be restored. Therefore, it can be seen that the high-quality mitochondria obtained by customized culture and separation of the present invention can be used to treat a variety of diseases after transplantation, and show good results, which opens up new ways and possibilities for the treatment of a variety of diseases.
[0032] In another aspect, the present invention provides a use of a high-activity mitochondrial preparation in promoting cartilage repair.
[0033] In another aspect, the present invention provides a use of a high-activity mitochondrial preparation in improving the energy metabolism of myocardial cells, enhancing myocardial contractility or regulating the redox balance in cells, reducing oxidative stress damage to neurons or restoring the activity of liver cells.
[0034] The beneficial effects of the present invention are:
[0035] 1. The present invention provides a method for producing high-quality mitochondria in vitro, which does not require invasive operations on the liver and muscles. It only needs to use the customized serum-free culture medium of the present invention for in vitro culture to culture and isolate a large number of high-quality and high-activity mitochondria; the mesenchymal stem cells obtained by the culture have stronger proliferation ability and meet the standards for mesenchymal stromal cells formulated by the International Association for Cell Therapy, as well as better adipogenic, chondrogenic, and osteogenic differentiation abilities and stronger cloning ability; at the same time, the mitochondria isolated from human adipose stem cells have more mitochondria, among which the protein content is significantly increased, and significantly more ATP is produced, and the reactive oxygen content is significantly reduced, and have stronger activity and function.
[0036] 2. The present invention provides a method for producing high-quality mitochondria in vitro, which uses a customized serum-free culture medium to culture and isolate a large number of safe and functional mitochondria. The customized culture medium does not contain animal-derived components and has lower costs. It can obtain mitochondria-rich stem cells, and the isolated mitochondria are of stable source and strong activity, which can meet the needs of mitochondrial transplantation therapy.
[0037] 3. The present invention provides a method for producing high-quality mitochondria in vitro, which obtains a large number of high-quality mitochondria through customized serum-free culture medium. The mitochondria have good effects on cartilage damage and anti-aging after transplantation, and also show good effects in the treatment of cardiovascular diseases, nervous system diseases, fatty liver and other diseases. This provides a new technical means for the manufacture of producible and sustainable high-quality mitochondria, opens up new pathways and possibilities for the treatment of various mitochondrial-related diseases, breaks through the current limitations of obtaining mitochondria through invasive operations, and has good application prospects. BRIEF DESCRIPTION OF THE DRAWINGS
[0038] Figure 1 The results of cell morphology of human adipose stem cells in different groups under a microscope.
[0039] Figure 2 The graphs show the cell growth curves in different groups.
[0040] Figure 3 The diagram shows the results of cell phenotype detection in different groups.
[0041] Figure 4 Shown are the three-lineage differentiation diagrams and quantitative analysis results in different groups.
[0042] Figure 5 The results of the clone-forming ability of human adipose stem cells in different groups are shown in Figure 2.
[0043] Figure 6 The results of mitochondrial morphology and quantity in different groups under electron microscope.
[0044] Figure 7 The figure shows the results of mitochondrial protein content determination in different groups.
[0045] Figure 8 The graph shows the results of ATP content produced by MSCs in different groups.
[0046] Fig. 9 The graph shows the proportion of depolarized mitochondria in different groups.
[0047] Fig.10 The results show the total ROS level in MSCs cells in different groups.
[0048] Fig.11 The graph shows the ATP content produced by mitochondria isolated from different groups.
[0049] Fig.12 The graph shows the membrane potential detection results of mitochondria isolated from different groups.
[0050] Fig.13The following are the results of mitochondrial activity obtained by culturing with different components of culture medium in Examples 1 to 14.
[0051] Fig.14 The following are the results of mitochondrial activity obtained by culturing with different components of culture medium in Examples 15 and 16.
[0052] Fig.15 The following are the results of mitochondrial activity obtained by culturing with different components of culture medium in Examples 16 to 25.
[0053] Fig.16 This is the staining result of mouse cartilage repair after transplanting mitochondria cultured in different groups of culture media.
[0054] Fig.17 This is the OARSI scoring result of cartilage damage in mice after transplantation of mitochondria cultured in different groups of culture media.
[0055] Fig.18 This is a bar chart showing the changes in fat and muscle content in aging mice in different groups.
[0056] Fig.19 This is a bar chart showing the changes in abdominal fat content in aging mice in different groups.
[0057] Fig. 20 The figure shows the changes in exercise capacity (movement distance and movement speed) of aging mice in different groups. DETAILED DESCRIPTION
[0058] The present invention is further described in detail below in conjunction with the accompanying drawings and embodiments. It should be pointed out that the embodiments described below are intended to facilitate the understanding of the present invention and do not have any limiting effect on the present invention.
[0059] Unless otherwise specified, the experimental methods used in the following examples are conventional methods.
[0060] Unless otherwise specified, the materials and reagents used in the following examples can be obtained from commercial sources.
[0061] Example 1 A method for preparing a preparation that can stably and continuously provide high-quality mitochondria
[0062] In order to meet clinical needs and successfully obtain a large number of high-quality mitochondria with stable sources and strong activity, a new customized mesenchymal stem cell culture system was first constructed in this embodiment, which can significantly improve the cell proliferation ability and mitochondrial biosynthesis ability, and a large number of high-quality mitochondria were isolated from the cultured mesenchymal stem cells. The transplantation treatment effect of the mitochondria in tissue regeneration, anti-aging and other diseases was further verified, and it was found that it can not only be used in the treatment of tissue regeneration, aging and aging degenerative diseases, but also in the treatment of other cardiovascular diseases, nervous system diseases, fatty liver and other diseases, the effect is also very significant. The specific research steps are as follows:
[0063] 1. Establishment of a customized training system
[0064] 1. Preparation of culture medium
[0065] (1) Preparation of serum-free culture medium
[0066] Serum-free medium was prepared: each 500 ml of DMEM / F12 medium (11320033, Gibco, USA) contained the following additives, and the concentrations of the additives in the serum-free medium were: sodium bicarbonate 1-5 g / L, insulin-transferrin-selenium (including insulin 5-20 μg / ml, transferrin 2-10 μg / ml, selenium 20-100 ng / ml), basic fibroblast growth factor 5-10 ng / ml, lipid concentrate with clear chemical composition (the lipid concentrate includes 12 lipid components, which will not be described in detail here) , replaced by purchase information, item number 11905-031, Gibco, available from https: / / www.thermofisher.cn / cn / zh / home / technical-resources / media-formulation.249.html) 0.1%-1%, progesterone 10-50nM, hydrocortisone 10-100nM, L-ascorbic acid 10-200μM, heparin sodium 1-100μg / ml, human platelet lysate 1%-5%, penicillin / streptomycin 1%.
[0067] Among them, in this embodiment, it specifically includes sodium bicarbonate 1g / L, insulin-transferrin-selenium (including insulin 10μg / ml, transferrin 5.5μg / ml, selenium 67ng / ml), basic fibroblast growth factor 5ng / ml, lipid concentrate with clear chemical composition 0.1%, progesterone 10nM, hydrocortisone 15nM, L-ascorbic acid 10μM, heparin sodium 1μg / ml, human platelet lysate 1%, penicillin / streptomycin 1%;
[0068] (2) Preparation of control group culture medium
[0069] The control group culture medium was prepared: 500 ml of L-DMEM culture medium (low-glucose DMEM, 11885084, Gibco, USA) contained 10% fetal bovine serum and 1% penicillin / streptomycin.
[0070] 2. Treatment of cultured cells
[0071] (1) Obtaining human adipose stem cells: The adipose tissue was rinsed in PBS containing 1% penicillin / streptomycin for 5 minutes, and the surface fascia and vascular tissue were removed with sterile instruments. The adipose tissue was minced and 0.2% type I collagenase was added and digested in an incubator. After more than 90% of the tissue was dissociated, it was filtered with a 70 μm cell sieve and centrifuged to collect primary cells for subsequent freezing and subculture.
[0072] (2) Experimental group: Human adipose-derived stem cells were seeded to 10 cm 2 In a culture dish, 5000 cells / cm 2 The cells were inoculated at a cell density of 100 μg / mL and the serum-free medium in step 1 was used as the culture medium. The medium was changed every two days. After 3 days of culture, the cells were digested and subcultured. Cell morphology, proliferation, cell phenotype, and trilineage differentiation ability were tested at different generations.
[0073] (3) Control group: The culture method and detection method are the same as those of the experimental group, and the culture medium is the control group culture medium (containing serum) in step 1.
[0074] 3. Analysis of experimental results
[0075] (1) Primary cell culture of ADSCs
[0076] During the above-mentioned cell culture process, the morphology of human adipose stem cells in the experimental group and the control group was observed and recorded using a microscope. Figure 1 As shown, the common MSCs group is the cell morphology of 3 different human adipose stem cell samples in the control group under the microscope, and the high-energy MSCs is the cell morphology of 3 corresponding human adipose stem cell samples in the experimental group under the microscope. Figure 1 It can be seen that human adipose stem cells have more cells, smaller cell area, and increased nuclear-cytoplasmic ratio in a serum-free culture environment.
[0077] In addition, traditional serum-free culture media have problems such as poor cell proliferation after several generations of culture, complex ingredients, and high prices. The customized serum-free culture system of the present invention can successfully passage MSCs cells for at least 16 generations by accurately adjusting the components and optimizing the culture conditions. It can not only maintain the good growth state and phenotypic characteristics of the cells, but also significantly improve the proliferation activity of the cells. At the same time, it reduces the culture cost, simplifies the composition, and overcomes many disadvantages of existing serum-free culture media.
[0078] (2) Cell proliferation
[0079] The growth curve was drawn using the cell counting method. The time required for the number of cells on the growth curve to double was the population doubling time (PDT), calculated using the formula: PDT = culture time (h) × log2 / log (final cell number / initial cell number).
[0080] Specific as Figure 2 As shown, the tc-Mito group is the cell growth curve of the control group, and the mc-Mito group is the cell growth curve of the experimental group. Figure 2 It can be seen that before the P5 generation, the experimental group showed faster cell proliferation ability than the control group, and the occurrence of PDT in the experimental group was significantly reduced.
[0081] (3) Cell phenotype
[0082] The cultured human adipose stem cells were collected, incubated with CD34, CD45, CD73, CD90 and CD105 antibodies, and identified and detected by flow cytometry (CytoFlex, Beckman).
[0083] Specific as Figure 3 As shown, Figure 3 The cell phenotype detection results of the experimental group and the control group of this embodiment are shown in FIG. Figure 3 It can be seen that the human adipose stem cells obtained from the experimental group expressed more than 97% positive expressions of CD73, CD90 and CD105, and did not express negative expressions of CD34 and CD45, which is in line with the standard definition of mesenchymal stromal cells established by the International Society for Cell Therapy. It also shows that the human adipose stem cells obtained from the experimental group have high quality and purity.
[0084] (4) Three-series functions
[0085] Identification of three-lineage differentiation ability: The cultured human adipose stem cells were induced to differentiate into adipogenesis, osteogenesis and cartilage, respectively. The specific process and results are shown below.
[0086] ① Adipogenic differentiation: 5×10 4 cells / cm 2The cells were inoculated at a density of . After 24 hours, the culture medium was replaced with an adipogenic differentiation medium, which was H-DMEM (high-glucose DMEM, 11965092, Gibco, USA) supplemented with 10% FBS, 1 μM dexamethasone, 500 μM 3-isobutyl-1-methylxanthine, and 200 μM indomethacin. After 14 days, the cells were fixed in 4% PFA (paraformaldehyde) for 30 minutes, and the lipid droplets of the differentiated cells were stained with oil red. The stained samples were observed with an inverted microscope (IX73, Olympus, USA). For quantitative analysis, 100% isopropanol was added to the wells and incubated for 30 minutes. The supernatant was transferred, and the absorbance was measured at 510 nm to obtain the OD value of the dye.
[0087] ② Osteogenic differentiation: 1×10 4 cells / cm 2 The cells were seeded at a density of . After 24 hours, the culture medium was replaced with osteogenic differentiation medium, which was H-DMEM supplemented with 10% FBS, 0.1 μM dexamethasone, 50 μM Vc and 10 mM β-glycerophosphate. After 21 days, the cells were fixed in 95% ethanol and stained with 2% Alizarin Red solution. The stained calcium-rich extracellular matrix was observed under an inverted microscope. For quantitative analysis, 5% sodium dodecyl sulfate was added to the wells together with hydrochloric acid and incubated for 30 minutes. The supernatant was transferred and the absorbance was measured at 405 nm to obtain the OD value of the dye.
[0088] ③ Chondrogenic differentiation: 5×10 4 cells / cm 2 Cells were seeded at a density of 100 μg / ml. After 24 hours, the chondrogenic differentiation medium was replaced with H-DMEM supplemented with 1% sodium pyruvate, 1% ITS, 100 nM dexamethasone, 50 μg / ml Vc, and 10 ng / ml TGF-β3 (transforming growth factor-β3). After 21 days, the production of glycosaminoglycans (GAGs) was determined by Alcian blue staining and observed under an inverted microscope. For quantitative analysis, the samples were digested and reacted with 1,9-dimethylmethylene blue (DMMB) dye. The OD value of the solution was then determined by absorbance at 525 nm.
[0089] The specific results are shown in 4. Figure 4 The three-line differentiation diagram of the experimental group and the control group of this embodiment, from Figure 4 It can be seen that the human adipose stem cells cultured in the experimental group have better adipogenic, chondrogenic and osteogenic differentiation abilities.
[0090] (5) Clone formation experiment
[0091] The cells were seeded in 6-well plates, with about 200 cells per well, and cultured for 14 days. The cells were fixed with 4% PFA and then stained with 0.1% crystal violet methanol solution at room temperature for 20 minutes. After removing the dye, the clone formation was observed under a microscope. Figure 5 As shown, from Figure 5 It can be seen that the human adipose stem cells cultured in the experimental group have stronger cloning ability.
[0092] 2. Obtaining high-quality mitochondria with stable sources and strong activity
[0093] 1. Electron microscopic observation of mitochondrial morphology and quantity: Using transmission electron microscopy (Philips Tecnai 10TEM), it was observed that the mitochondria in the experimental group MSCs were short rod-shaped and the number of mitochondria was greater. Figure 6 shown.
[0094] 2. Determination of mitochondrial content: Use a cell mitochondrial isolation kit (C3601, Beyotime, China) combined with a glass homogenizer to isolate mitochondria. Suspend the cell pellet in 1 ml of ice-thaw buffer, incubate for 15 minutes, and then homogenize 20-30 times. Centrifuge at 600g for 10 minutes at 4°C to remove cell debris, and collect mitochondria by centrifugation at 11000g for 10 minutes at 4°C. Rinse the mitochondrial microspheres with 1 ml of mitochondrial storage buffer and centrifuge at 11000g for 10 minutes at 4°C. The isolated mitochondria are used for subsequent experiments. The protein concentration of the mitochondrial content is determined using an enhanced BCA protein assay kit (P0010, Beyotime, China). Specifically, Figure 7 As shown, compared with the control group, the mitochondrial protein content in MSCs in the experimental group was significantly increased.
[0095] 3. ATP detection: Use the enhanced ATP assay kit (S0027, Beyotime, China) to measure the ATP content produced by MSCs according to the manufacturer's instructions. Figure 8 As shown, it can be seen that compared with the control group, significantly more ATP was produced in MSCs in the experimental group.
[0096] 4. Membrane potential detection: According to the manufacturer's instructions, the mitochondrial membrane potential of MSCs was detected using an enhanced membrane potential detection kit containing JC-1 (C2003S, Beyotime, China). Fig. 9 As shown, compared with the control group (10.10%), the depolarized mitochondria of MSCs in the experimental group were only 4.32%, and the proportion of depolarized mitochondria was significantly reduced, indicating that the mitochondrial activity in the MSCs in the experimental group was stronger.
[0097] 5. Reactive oxygen species detection: According to the manufacturer's instructions, the total intracellular ROS level of MSCs was detected using a ROS detection kit (S0033, Beyotime, China). Fig.10 As shown, compared with the control group, the reactive oxygen species produced by MSCs in the experimental group were significantly reduced, which indicates that the mitochondrial activity in the MSCs in the experimental group was stronger.
[0098] 6. Characterization of isolated mitochondria: As described in steps 3 and 4, separate the mitochondria and perform ATP and membrane potential detection again, as follows: Fig.11 and Fig.12 As shown, from Fig.11 and Fig.12 It can be seen that compared with the control group, the mitochondria in the experimental group significantly produced more ATP and had a higher membrane potential, which indicates that the mitochondria in the experimental group were more active and functioned better.
[0099] In this embodiment, a customized culture system is preferably used to have the best synergistic culture system, thereby significantly improving the cell proliferation ability and mitochondrial biosynthesis ability. The mesenchymal stem cells obtained by the culture have a stronger proliferation ability and meet the standards for mesenchymal stromal cells formulated by the International Association for Cell Therapy, as well as better adipogenic, chondrogenic, osteogenic, and chondrogenic differentiation abilities and stronger cloning ability, and can be successfully passaged for 16 generations. At the same time, the mitochondria isolated from human fatty liver cells have a larger number of mitochondria, a significantly increased protein content, and significantly more ATP is produced, the reactive oxygen content is significantly reduced, and the cells have stronger activity and function.
[0100] Example 2 Screening of the best customized culture system of the present invention
[0101] In order to successfully obtain a large number of high-quality mitochondria with a stable source and strong activity, a large number of culture systems were screened in this example, and mitochondrial activity was used as a detection indicator to screen the most suitable culture system for culturing high-quality mitochondria with the best activity and function. The specific screening steps are as follows:
[0102] 1. Preliminary screening of the best components in serum-free culture medium
[0103] In this embodiment, the initial serum-free culture medium is specifically as shown in Example 1, and any one component is deleted on the basis of Example 1, as described in Examples 2 to 14, and the culture effects of different culture media are detected.
[0104] 1. The serum-free medium of Example 1 is specifically as follows: each 500 ml of DMEM / F12 medium (containing 1% penicillin / streptomycin) contains the following additional components, and the concentration of the additional components in the serum-free medium is:
[0105] Platelet-derived growth factor AA 1-100ng / ml (10ng / ml),
[0106] Platelet-derived growth factor AB 1-100ng / ml (10ng / ml),
[0107] Basic fibroblast growth factor 5-10ng / ml (5ng / ml),
[0108] Transforming growth factor-β1 1-10ng / ml (5ng / ml),
[0109] Fibronectin 1-10 μg / ml (2 μg / ml),
[0110] Sodium bicarbonate 1-5g / L (1g / L),
[0111] Lipid concentrate 0.1%-1% (0.1%),
[0112] Insulin-transferrin-selenium (insulin 5-20μg / ml, transferrin 2-10μg / ml, selenium 20-100ng / ml),
[0113] Putrescine 10-100 μM (20 μM),
[0114] Progesterone 10-50nM (10nM),
[0115] Hydrocortisone 10-100nM (15nM),
[0116] L-ascorbic acid 10-200 μM (10 μM),
[0117] Heparin sodium 1-100 μg / ml (1 μg / ml).
[0118] 2. In Example 2, the composition of the serum-free culture medium is the same as that in Example 1 except that platelet-derived growth factor AA is removed.
[0119] 3. In Example 3, the composition of the serum-free culture medium is the same as that in Example 1 except that platelet-derived growth factor AB is removed.
[0120] 4. In Example 4, the composition of the serum-free culture medium is the same as that of Example 1 except that basic fibroblast growth factor is removed.
[0121] 5. In Example 5, the composition of the serum-free culture medium is based on Example 1 without transforming growth factor-β1.
[0122] 6. In Example 6, the composition of the serum-free culture medium is the same as that of Example 1 except that fibronectin is removed.
[0123] 7. In Example 7, the composition of the serum-free culture medium is the same as that of Example 1 except that sodium bicarbonate is removed.
[0124] 8. In Example 8, the composition of the serum-free culture medium is the same as that of Example 1 without the lipid concentrate.
[0125] 9. In Example 9, the composition of the serum-free culture medium is based on Example 1 without insulin-transferrin-selenium.
[0126] 10. In Example 10, the composition of the serum-free culture medium is the same as that of Example 1 except that putrescine is removed.
[0127] 11. In Example 11, the composition of the serum-free culture medium is the same as that of Example 1 except that progesterone is removed.
[0128] 12. In Example 12, the composition of the serum-free culture medium is the same as that of Example 1 except that hydrocortisone is removed.
[0129] 13. In Example 13, the composition of the serum-free culture medium is the same as that of Example 1 except that L-ascorbic acid is removed.
[0130] 14. In Example 14, the composition of the serum-free culture medium is the same as that of Example 1 except that sodium heparin is removed.
[0131] The specific steps for testing the culture effects of different serum-free culture media are as follows:
[0132] Human adipose-derived stem cells with a confluence of 80% were seeded into 10 cm 2 In a culture dish, 3000 cells / cm 2 The cells were inoculated at a density of 100 μg / mL and the serum-free culture medium of Examples 1 to 14 was used respectively. The medium was changed every two days and the cells were cultured in an incubator at 37°C and 5% CO2. After 3 days of culture, the cells were rinsed twice with PBS, stained with MitoTracker-Red (mitochondrial tracer) for 15 minutes, and then rinsed three times with PBS. Pictures were taken under a fluorescence microscope, and the fluorescence intensity was calculated using ImageJ software.
[0133] Test results such as Fig.13 As shown, from Fig.13 It can be seen that compared with Example 1, Examples 2, 3, 5, 6, 7, and 10 have stronger relative mitochondrial activity, which indicates that after removing the components: "platelet-derived growth factor AA, platelet-derived growth factor AB, transforming growth factor-β1, fibronectin, sodium bicarbonate, putrescine", the serum-free medium has a better effect, so the above components are removed in Example 1. In view of the importance of sodium bicarbonate to the basic function of the culture medium, it is not removed for the time being.
[0134] 2. Further screening of optimal components in serum-free culture medium
[0135] After preliminary screening, a serum-free medium as shown in Example 15 was obtained, specifically: each 500 ml of DMEM / F12 medium (containing 1% penicillin / streptomycin) contained the following added components, and the concentration of the added components in the serum-free medium was:
[0136] Basic fibroblast growth factor 5-10ng / ml (5ng / ml),
[0137] Sodium bicarbonate 1-5g / L (1g / L),
[0138] Lipid concentrate 0.1%-1% (0.1%),
[0139] Insulin-transferrin-selenium (insulin 5-20μg / ml, transferrin 2-10μg / ml, selenium 20-100ng / ml),
[0140] Progesterone 10-50nM (10nM),
[0141] Hydrocortisone 10-100nM (15nM),
[0142] L-ascorbic acid 10-200 μM (10 μM),
[0143] Heparin sodium 1-100 μg / ml (1 μg / ml).
[0144] Further, 1%-5% (1%) of human platelet lysate was added to the serum-free culture medium of Example 15 to obtain the serum-free culture medium of Example 16, and the culture effects of different culture media were tested. The specific testing steps are as follows:
[0145] Human adipose-derived stem cells with a confluence of 80% were seeded into 10 cm 2 In a culture dish, 3000 cells / cm 2 The cells were inoculated at a cell density of 100 μg / cm2 and the serum-free culture medium of Example 15 and Example 16 was used respectively. The medium was changed every two days and the cells were cultured in an incubator at 37°C and 5% CO2. After 3 days of culture, the cells were rinsed twice with PBS, stained with MitoTracker-Red for 15 minutes, and then rinsed three times with PBS. Pictures were taken under a fluorescence microscope and the fluorescence intensity was calculated using ImageJ software. The test results are shown in Figure 2. Fig.14 As shown, from Fig.14It can be seen that compared with Example 15, the relative mitochondrial activity of Example 16 is higher, which indicates that adding human platelet lysate is important for improving mitochondrial activity. This may be because human platelet lysate can provide rich nutrients and growth factors on the one hand, promote cell growth, proliferation and differentiation, and maintain the good state of cells, improve the adaptability of cells to the environment, and thus significantly improve the activity of mitochondria obtained by culture. On the other hand, basic fibroblast growth factor promotes cell proliferation and differentiation, stimulates cell growth, and insulin-transferrin-selenium provides cells with necessary nutrition and metabolic support to ensure normal cell metabolism. When basic fibroblast growth factor, insulin-transferrin-selenium and human platelet lysate are used in synergy, they work together by jointly regulating intracellular signaling pathways and affecting gene expression, further stimulating cell growth and ensuring normal cell metabolism, thereby significantly improving mitochondrial function and ultimately significantly promoting the enhancement of mitochondrial activity.
[0146] 3. Re-screening of the best components in serum-free culture medium
[0147] After further screening, a serum-free culture medium as shown in Example 16 was obtained, and any one component was deleted on the basis of Example 16, as described in Examples 17 to 25, and the culture effects of different culture media were tested.
[0148] 1. In Example 17, the composition of the serum-free culture medium is the same as that of Example 16 except that basic fibroblast growth factor is removed.
[0149] 2. In Example 18, the composition of the serum-free culture medium is based on Example 16 without sodium bicarbonate.
[0150] 3. In Example 19, the composition of the serum-free culture medium is the same as that of Example 16 without the lipid concentrate.
[0151] 4. In Example 20, the composition of the serum-free culture medium is that of Example 16 without insulin-transferrin-selenium.
[0152] 5. In Example 21, the composition of the serum-free culture medium is based on Example 16 without progesterone.
[0153] 6. In Example 22, the composition of the serum-free culture medium is the same as that of Example 16 except that hydrocortisone is removed.
[0154] 7. In Example 23, the composition of the serum-free culture medium is the same as that of Example 16 except that L-ascorbic acid is removed.
[0155] 8. In Example 24, the composition of the serum-free culture medium is based on Example 16 without sodium heparin.
[0156] 9. In Example 25, the composition of the serum-free culture medium is the same as that of Example 16 except that the human platelet lysate is removed.
[0157] The specific steps for testing the culture effects of different serum-free culture media are as follows:
[0158] Human adipose-derived stem cells with a confluence of 80% were seeded into 10 cm 2 In a culture dish, 3000 cells / cm 2 The cells were inoculated at a density of 100 μg / cm2 and the serum-free culture medium of Examples 1 to 14 was used respectively. The medium was changed every two days and the cells were cultured in an incubator at 37°C and 5% CO2. After culturing for 3 days, the cells were rinsed twice with PBS, stained with MitoTracker-Red for 15 minutes, and then rinsed three times with PBS. Pictures were taken under a fluorescence microscope and the fluorescence intensity was calculated using ImageJ software. The test results are shown in FIG. Fig.15 As shown, from Fig.15 It can be seen that compared with Example 16, the relative mitochondrial activity of Examples 17-25 decreased, which indicates that each component in Example 16 can promote mitochondrial activity and under the synergistic effect of different components, the mitochondrial activity obtained by culture can be significantly enhanced.
[0159] Among them, the functions of each optimal culture medium component in Example 16 are as follows:
[0160] ① Basic fibroblast growth factor: It can stimulate cell proliferation, differentiation and migration, help cell growth and development in culture medium, and promote mitochondrial-related cell activities and functions;
[0161] ②Sodium bicarbonate: Mainly used to adjust the pH value of the culture medium, maintain a suitable pH environment, and facilitate the normal physiological activities of cells and mitochondria;
[0162] ③Lipid concentrate: provides cells with essential lipid components, supports the formation and stability of cell membranes, and plays a certain role in the construction and function of mitochondrial membranes;
[0163] ④Insulin-transferrin-selenium: Insulin can regulate cell metabolism and growth, transferrin helps transport iron ions, and selenium has antioxidant effects, providing nutrition and protection for cells and mitochondria as a whole;
[0164] ⑤ Progesterone: has a certain influence on the physiological regulation of cells;
[0165] ⑥ Hydrocortisone: It has a certain effect on regulating cell metabolism and stress response, and maintains mitochondrial function;
[0166] ⑦L-ascorbic acid: vitamin C, which has antioxidant effects and can protect cells and mitochondria from oxidative damage;
[0167] ⑧ Heparin sodium: helps maintain the stability of the culture medium and is conducive to the normal culture of cells and mitochondria;
[0168] ⑨Penicillin / Streptomycin: inhibit bacterial contamination and ensure the purity of the cell culture environment, thus facilitating the normal culture of mitochondria;
[0169] ⑩Human platelet lysate: It can provide rich nutrients and growth factors to promote cell growth, proliferation and differentiation. At the same time, it can maintain the good state of cells, improve the cell's ability to adapt to the environment, and increase mitochondrial activity.
[0170] At the same time, there is a significant synergistic effect between the above-mentioned different components, which can significantly enhance mitochondrial activity, as follows:
[0171] When basic fibroblast growth factor, insulin-transferrin-selenium and human platelet lysate are used together, multiple growth factors work synergistically by jointly regulating intracellular signal pathways and affecting gene expression, further promoting cell proliferation, differentiation and mitochondrial biosynthesis and ensuring normal cell metabolism, thereby significantly improving mitochondrial function and promoting mitochondrial activity.
[0172] L-ascorbic acid has an antioxidant effect that can protect cells and mitochondria from oxidative damage; it works synergistically with other components in human platelet lysate to further enhance the antioxidant defense system, thereby maintaining the normal function of mitochondria.
[0173] Progesterone and hydrocortisone work synergistically to regulate cell growth, differentiation, and metabolism.
[0174] Therefore, Preferred Example 16 in this embodiment is the best formula for serum-free culture medium, and the best components are all indispensable ingredients. Through the synergistic effect among the above components, the activity and function of mitochondria are significantly enhanced.
[0175] Example 3 Application of mitochondria cultured and isolated by the present invention in transplantation for the treatment of osteoarthritis
[0176] Using the optimal culture system customized by the present invention, a large number of the above-mentioned high-quality mitochondria are isolated from MSCs, and in subsequent studies, the application of the mitochondria in the treatment of cartilage damage, anti-aging, etc. is further verified. In this embodiment, the mitochondria isolated by the culture are transplanted and used to treat osteoarthritis, and the specific steps are as follows:
[0177] 1. Construction of mouse osteoarthritis (OA) model: In this embodiment, the mice were 8-week-old male C57BL / 6 mice purchased from Zhejiang Weitong Lihua Experimental Animal Technology Co., Ltd. The experimental scheme is as follows: Make a 1 cm longitudinal incision along the distal patellar tendon. Expose the medial meniscus and then remove it with surgical scissors along the lower edge of the meniscus. Then suture the medial capsule incision and close the skin. All surgical procedures follow the principle of sterility. Four weeks after surgery, intra-articular injections were performed once a week for 4 consecutive weeks. The mice were randomly divided into 3 groups: a sterile PBS group, a normal mitochondria group, and a high-energy mitochondria group. The mice were killed 8 and 12 weeks after surgery, and the knee joints were collected for further experiments.
[0178] 2. Histological scoring: The knee joint specimens were fixed with 4% PFA for 48 hours and then decalcified in 10% disodium ethylenediaminetetraacetic acid (EDTA) solution for 2 weeks. They were then embedded in paraffin, cut into 5 μm thick sections, and stained with safranin O / fast green (SO / FG). Fig.16 As shown, from Fig.16 It can be seen that compared with the sterile PBS group and the ordinary mitochondria group, the cartilage surface of the mice injected with high-energy mitochondria was smoother and flatter, reducing the loss of cartilage matrix components caused by osteoarthritis cartilage destruction. At the same time, histological scoring was performed according to the OARSI scoring system (0-6), and the average and maximum scores were calculated. Fig.17 As shown, the degree of cartilage lesions is divided into different levels from 0 to 6, where 0 represents normal cartilage, and higher levels indicate more severe cartilage damage and degeneration; the average score reflects the overall situation; the maximum score reflects the score of the most severe sample. Fig.17 It can be seen that in the sterile PBS group and the ordinary mitochondria group, the damage to the knee cartilage of mice was significantly aggravated over time; while in the mice injected with high-energy mitochondria, the cartilage was significantly repaired.
[0179] Similarly, in the Chinese invention patent "Application of iMSCs mitochondria in the preparation of drugs for treating bone defects" with application publication number CN117180312A, mitochondria are isolated by in vitro culture of iMSCs to treat bone defects. On the one hand, in this application, the in vitro production method of mitochondria is completely different from that of the present invention, and it is cultured using complete culture medium; at the same time, in order to further verify that the mitochondria cultured and isolated by the customized culture system of the present invention have better effects, the mitochondria are cultured and isolated in vitro according to the serum-free culture system of the present invention and the complete culture medium culture system in the comparative document, and the OA model is constructed according to the steps of this embodiment, so as to compare the effects of mitochondria obtained under different culture systems. The experimental results show that compared with the mitochondria cultured using complete culture medium in the comparative document, after the injection of the mitochondria of the present invention, the morphology of mouse cartilage is significantly improved, the surface of the cartilage is smoother, and the number of chondrocytes increases and the arrangement is more compact and orderly; at the same time, the OARSI score is also significantly reduced. Therefore, the above results all show that compared with the mitochondria cultured using complete culture medium in the comparative document, the mitochondria cultured and isolated by the customized serum-free culture system of the present invention have more significant cartilage damage repair effects.
[0180] Therefore, it can be seen that the high-energy mitochondria cultured in the present invention can significantly promote the repair of OA cartilage damage in mice and has broad application prospects.
[0181] Example 4 Application of mitochondria isolated by culture in the present invention in transplantation for the treatment of aging and aging-related degenerative diseases
[0182] In this embodiment, the mitochondria isolated by the culture are transplanted and used to treat aging and aging-related degenerative diseases. The specific steps are as follows:
[0183] 1. Healthy aged mice (14 months old) were selected and randomly divided into 2 groups: sterile PBS group and high-quality mitochondria group. Each group of mice was injected with tail vein once every 3 weeks and tested after 14 weeks.
[0184] 2. The experimental results show that compared with the sterile PBS group, the body fat content of the aged mice was significantly reduced and the muscle content was significantly increased after the mitochondria cultured in the experimental group were transplanted. Fig.18 At the same time, the abdominal fat content of mice in the mitochondrial transplantation group was also significantly reduced, as shown in Fig.19 In addition, the open field test showed that the exercise capacity of the mice in the mitochondrial transplantation group was significantly stronger than that in the control group, as shown by the increase in exercise distance and exercise speed. Fig. 20 shown.
[0185] Therefore, it can be seen that the high-energy mitochondria cultured and isolated in the present invention can improve the aging indicators of aging mice after transplantation, indicating that it has potential application value in the treatment of aging and aging-related degenerative diseases.
[0186] Example 5 Application of mitochondria isolated by culture in the present invention and transplantation in various other diseases
[0187] It is known that mitochondria are eukaryotic organelles that participate in the synthesis and regulation of adenosine triphosphate (ATP), a source of energy within the cell. Mitochondria participate in a variety of metabolic pathways in the body, such as cell signaling, cell differentiation and apoptosis, as well as the control of the cell cycle and cell growth. Mitochondria are organelles with their own genomes that play a central role in the energy metabolism of cells, such as energy generation through electron transfer and oxidative phosphorylation processes, and participation in cell death signal transduction pathways.
[0188] It has been reported that reduced energy production due to decreased mitochondrial function leads to a variety of diseases. When the function of the electron transport chain reaction deteriorates due to mutations in the mitochondrial genome and proteome, reduced ATP production, excessive production of reactive oxygen species, and decreased calcium regulation function occur. In this case, the membrane permeability of the mitochondria changes, leading to abnormal cell death function, which can lead to cancer and incurable diseases. Therefore, human diseases caused by mitochondrial dysfunction include mitochondrial-related genetic diseases, diabetes, heart disease, Parkinson's disease, Alzheimer's disease and other senile dementias, and the occurrence and metastasis of various cancers. In addition, common features found in more than 200 different types of cancer include impaired apoptosis function, increased inflammatory response, and increased abnormal metabolic activity.
[0189] If there is a signal transduction mechanism closely related to cell death inside the mitochondria, and these signals can be interpreted and controlled, they can be applied to disease treatment. Mitochondrial dysfunction is not a single symptom or disease, but can appear in the form of multiple diseases in various organs of the human body, which increases the possibility of treatment for lesions and diseases related to mitochondria.
[0190] Therefore, in the present invention, a large number of high-quality and highly active mitochondria are cultured and isolated, in order to realize the possibility of treating mitochondrial-related lesions and diseases after transplantation.
[0191] At the same time, in this embodiment, the application of mitochondria obtained by culture and separation of the present invention in various other diseases was further studied. The experimental results of the preliminary study show that: in the treatment of cardiovascular diseases, after the mitochondria are transplanted, the energy metabolism of myocardial cells can be effectively improved, the myocardial contractility can be enhanced, and the energy required for the normal operation of the heart can be provided; in nervous system diseases, such as Parkinson's disease, after the mitochondria are transplanted, the redox balance in the cells can be successfully regulated, the oxidative stress damage of neurons can be reduced, and the normal function of neurons can be maintained; in the treatment of fatty liver, after the mitochondria are transplanted, the energy production of the liver can be effectively improved, the lipid accumulation and oxidative damage of the liver can be reduced, and the activity of liver cells can be restored.
[0192] Therefore, it can be seen from the above results that the high-quality mitochondria obtained by customized culture and separation of the present invention can be used to treat a variety of diseases after transplantation, and have shown good effects, which has opened up new avenues and possibilities for the treatment of a variety of diseases.
[0193] Although the present invention has been disclosed as above in the form of a preferred embodiment, it is not intended to limit the present invention. Anyone familiar with this technology can make various changes and modifications without departing from the spirit and scope of the present invention. Therefore, the scope of protection of the present invention should be based on the definition of the claims.
Claims
1. A method for producing highly active mitochondria in vitro, characterized in that: The following steps are involved: (1) Preparing a customized serum-free culture medium; (2) inoculating cells and culturing them using the serum-free medium in step (1); (3) Isolation of mitochondria; The serum-free culture medium in step (1) comprises basic fibroblast growth factor, insulin-transferrin-selenium, and human platelet lysate, and the three components synergistically enhance the mitochondrial activity; in the serum-free culture medium, the basal culture medium is DMEM / F12 culture medium and 1% penicillin / streptomycin.
2. The in vitro production method according to claim 1, characterized in that The serum-free culture medium also includes sodium bicarbonate, lipid concentrate, progesterone, hydrocortisone, L-ascorbic acid and heparin sodium.
3. The in vitro production method according to claim 2, characterized in that The serum-free culture medium comprises 1-5 g / L sodium bicarbonate, 1X insulin-transferrin-selenium, 5-10 ng / ml basic fibroblast growth factor, 0.1%-1% lipid concentrate, 10-50 nM progesterone, 10-100 nM hydrocortisone, 10-200 μM L-ascorbic acid, 1-100 μg / ml heparin sodium, and 1%-5% human platelet lysate.
4. A highly active mitochondrial preparation, characterized in that: The mitochondria in the preparation are cultured and isolated using the in vitro production method according to any one of claims 1 to 3.
5. Use of a serum-free culture medium for preparing a preparation for promoting cartilage repair, characterized in that: The serum-free culture medium is used to culture and separate highly active mitochondria in vitro, and a highly active mitochondrial preparation is prepared. After the highly active mitochondrial preparation is transplanted, the repair of cartilage damage is promoted.
6. The use according to claim 5, characterized in that The serum-free culture medium includes a basic culture medium of DMEM / F12 culture medium and 1% penicillin / streptomycin; and also includes basic fibroblast growth factor, insulin-transferrin-selenium, human platelet lysate, sodium bicarbonate, lipid concentrate, progesterone, hydrocortisone, L-ascorbic acid, and heparin sodium. The nine components synergistically enhance the mitochondrial activity and prepare a high-activity mitochondrial preparation.
7. The use according to claim 6, characterized in that The serum-free culture medium comprises 1-5 g / L sodium bicarbonate, 1X insulin-transferrin-selenium, 5-10 ng / ml basic fibroblast growth factor, 0.1%-1% lipid concentrate, 10-50 nM progesterone, 10-100 nM hydrocortisone, 10-200 μM L-ascorbic acid, 1-100 μg / ml heparin sodium, and 1%-5% human platelet lysate.
8. Use of a serum-free medium for preparing a preparation for reducing fat content, increasing muscle content, reducing abdominal fat content, or increasing movement distance and movement speed of aged mice, characterized in that: The serum-free culture medium is used to culture and separate highly active mitochondria in vitro, and a highly active mitochondrial preparation is prepared. After the highly active mitochondrial preparation is transplanted, the aging indicators of aging mice are improved, the fat content is reduced, and the muscle content is increased.
9. The use according to claim 8, characterized in that The serum-free culture medium includes a basic culture medium of DMEM / F12 culture medium and 1% penicillin / streptomycin; and also includes basic fibroblast growth factor, insulin-transferrin-selenium, human platelet lysate, sodium bicarbonate, lipid concentrate, progesterone, hydrocortisone, L-ascorbic acid, and heparin sodium. The nine components synergistically enhance the mitochondrial activity and prepare a high-activity mitochondrial preparation.
10. Use of a serum-free culture medium for preparing a preparation for improving the energy metabolism of cardiomyocytes, enhancing myocardial contractility or regulating the redox balance in cells, reducing oxidative stress damage to neurons or restoring the activity of hepatocytes, characterized in that: The serum-free culture medium includes a basic culture medium of DMEM / F12 culture medium and 1% penicillin / streptomycin; and also includes basic fibroblast growth factor, insulin-transferrin-selenium, human platelet lysate, sodium bicarbonate, lipid concentrate, progesterone, hydrocortisone, L-ascorbic acid, and heparin sodium. The nine components synergistically enhance the mitochondrial activity and prepare a high-activity mitochondrial preparation.
